Advertisement
Most physicians believe they have seen false-negative results for a COVID-19 diagnostic test

Most Physicians Have Seen False-Negative COVID-19 Test Results

0
One in 10 physicians worldwide report seeing at least one case of COVID-19 reinfection
Treating hospitalized COVID-19 patients with hydroxychloroquine

Hydroxychloroquine No Aid for COVID-Related Mortality

0
Hydroxychloroquine alone or with azithromycin associated with abnormal electrocardiogram findings
In a joint guidance document issued by the American Society for Bone and Mineral Research

Guidance Issued for Osteoporosis Management During COVID-19

0
Alternative methods for parenteral treatments include off-site clinics, home visit, self-injection
Regular aspirin use is associated with a lower risk for colorectal and other digestive tract cancers

Regular Aspirin Use Tied to Lower Risk for Digestive Tract Cancers

0
Favorable effect increases with longer duration of use, and, for colorectal cancer, with increasing dose
Intensive blood pressure control can lower the risk for atrial fibrillation in patients with hypertension at high risk for cardiovascular disease

Intensive Blood Pressure Control Tied to Lower Atrial Fibrillation Risk

0
Lowering systolic BP to <120 mm Hg lowers risk by 26 percent
In a stroke population

T2DM Linked to Worse Cognitive Performance After Stroke

0
No significant difference found in cognitive function for those with impaired, normal fasting glucose levels
In a special article from the American College of Physicians

ACP Advises Against Chloroquine, Hydroxychloroquine for COVID-19

0
Practice points based on lack of evidence supporting use as prophylaxis or treatment for COVID-19
A rapid COVID-19 test being used across the United States could miss infections

FDA: Abbott Rapid COVID-19 Test Could Miss Infections

0
Research has suggested that the Abbott ID NOW point-of-care test may return false-negative results
A number of COVID-19 vaccines under development "look pretty promising" and one or two could be ready for large-scale testing by July

NIH: Large-Scale Testing of Some COVID-19 Vaccines Could Start in July

0
About a dozen potential vaccines worldwide are in the initial stages of, or set to begin, testing in people
The National Institute of Allergy and Infectious Diseases announced it is sponsoring a phase 2b clinical trial to evaluate the efficacy and safety of hydroxychloroquine and azithromycin in preventing hospitalization and death from COVID-19.

NIH Launches Trial of Hydroxychloroquine, Azithromycin for COVID-19

0
Trial will enroll 2,000 patients with SARS-COV-2 who have fever, cough, and/or shortness of breath